Medical Ikkou Group announced its results for the first half of the fiscal year ending February 2027. Consolidated ordinary profit came in at ¥1.13 billion, up 29.0% year on year. The full-year plan is ¥1.85 billion, representing 61.4% progress.
Medical Ikkou Group announced its earnings after market close on 9 October, reporting consolidated ordinary profit of ¥1.13 billion for the first half of the fiscal year ending February 2027 (March-August), up 29.0% year on year. This was above its previous forecast of ¥950 million.
The company left its full-year plan unchanged at ¥1.85 billion, bringing progress to 61.4%. Based on this, second-half ordinary profit was projected at ¥710 million, down 27.0% year on year.
For the most recent three months, consolidated ordinary profit for June-August was ¥550 million, up 43.2% year on year, while the operating margin improved from 2.3% to 2.7%.